北京商报讯(记者丁宁)近日,默沙东在公布2024年业绩情况时宣布,将暂停向中国市场供应HPV疫苗(Gardasil/Gardasil 9,商品名:佳达修),此次供应暂停将至少持续至2025年年中。 默沙东表示,受整体市场环境、消费者需求疲软及渠道库存高等因素影响,公司与本土合作伙伴智飞生物进行深入沟通,决定自2025年2月起根据消费者需求的动态变化,阶段性调整中国市场的发货节奏,预计将于2025...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.